Related Experiment Video
Updated: Mar 29, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.7K
β2-AGONISTS IN CHILDHOOD ASTHMA
M Miraglia Del Giudice1, G Campana1, F Galdo1
1Department of Women, Child and General and Special Surgery, Second University of Naples, Italy.
Journal of Biological Regulators and Homeostatic Agents
|December 5, 2015
Summary
Short-acting beta-agonists (SABAs) provide quick relief for asthma symptoms, while long-acting beta-agonists (LABAs) offer sustained symptom control. This review examines recent data on these important asthma medications.
Area of Science:
- Pharmacology
- Respiratory Medicine
Background:
- Beta-2 agonists are bronchodilators that relax airway smooth muscle, improving airflow.
- They are classified by duration of action: short-acting (SABAs) and long-acting (LABAs).
Purpose of the Study:
- To review recent data on short-acting and long-acting beta-agonists.
- To highlight the clinical applications and differences between SABAs and LABAs.
Main Methods:
- Literature review of recent publications on beta-2 agonists.
- Analysis of pharmacodynamic properties and clinical use of SABAs and LABAs.
Main Results:
- SABAs (e.g., albuterol) have short half-lives (2-6h) and are used for "as needed" relief and exercise-induced bronchospasm.
- LABAs (e.g., salmeterol, formoterol) require twice-daily dosing and provide longer symptom control, including for nocturnal symptoms.
Conclusions:
- Beta-2 agonists are essential for managing airflow limitation in respiratory conditions.
- LABAs offer significant advantages for sustained symptom control compared to SABAs.
Related Concept Videos
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
2.0K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.0K
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
01:30Adrenergic Agonists: Therapeutic Uses
2.2K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.2K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
01:20Asthma: Pathogenesis and Management
1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.5K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K